Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.60p
   
  • Change Today:
      0.008p
  • 52 Week High: 3.96
  • 52 Week Low: 1.17
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 4,865,924
  • Market Cap: £21.47m
  • RiskGrade: 340

Latest ShareCast News

Hermogenyx shares soar on new partnership with Prevail Partners

By Benjamin Chiou

Date: Monday 18 Sep 2023

(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.

Hemogenyx signs another deal with unnamed global pharma company

By Josh White

Date: Wednesday 23 Oct 2019

(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.

Hemogenyx enters collaboration agreement with Orgenesis

By Iain Gilbert

Date: Friday 19 Oct 2018

(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement with cell therapy outfit Orgenesis to further commercialise its humanised-mouse drug model.

Hemogenyx inks lupus collaboration with Johnson ... 15-Oct-2018 ShareCast
Hemogenyx inks development agreement with new ph... 14-May-2018 ShareCast
Hemogenyx flies on back of 'humanised mouse' rep... 26-Feb-2018 ShareCast
Hemogenyx reverses into Silver Falcon, issues sh... 05-Oct-2017 ShareCast
Silver Falcon finally swoops for biotech Hemogen... 11-Sep-2017 ShareCast
Silver Falcon agrees broad terms for Lime insura... 30-Dec-2015 ShareCast
London pre-open: Stocks seen a little lower afte... 30-Dec-2015 ShareCast
Silver Falcon admits first takeover talks are at... 07-Dec-2015 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.60p
Change Today 0.008p
% Change -0.50 %
52 Week High 3.96
52 Week Low 1.17
Volume 4,865,924
Shares Issued 1,341.82m
Market Cap £21.47m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average48.28% below the market average
69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average
Price Trend
20.3% below the market average20.3% below the market average20.3% below the market average20.3% below the market average20.3% below the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 25-Apr-2024

Time Volume / Share Price
14:59 500,000 @ 1.58p
14:55 500,000 @ 1.58p
14:55 1,572 @ 1.58p
14:55 50,000 @ 1.58p
14:37 442 @ 1.56p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page